Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Achieving effective cost control while decreasing regulation. A response to Dr. Fein.

Medical Group Management

|December 11, 1984

Summary

Controlling healthcare costs requires balancing regulation and competition. The core debate centers on societal willingness to fund marginal life extension and the ethical decision-making framework for such choices.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disease management and ESRD: where does it stand in Washington?

Nephrology news & issues·2002

Same author

The Patients' Bill of Rights and Medicare prescription drug benefits.

The Journal of medical practice management : MPM·2001

Same author

Disease management: what have we learned so far?

Blood purification·2001

Same author

The first 100 days.

The Journal of medical practice management : MPM·2001

Same author

Last year in brief and major issues of the new millennium.

The Journal of medical practice management : MPM·2000

Same author

The economic impact of Staphylococcus aureus infection in New York City hospitals.

Emerging infectious diseases·1999

Area of Science:

Health economics
Healthcare policy
Medical ethics

Background:

Healthcare cost control is a significant challenge.
Debate exists on the optimal balance between regulation and market competition in healthcare.
Previous policy experience informs strategies for healthcare reform.

Purpose of the Study:

To explore differing perspectives on achieving healthcare cost control while reducing regulation.
To analyze the roles of competition, preferred provider organizations (PPOs), health maintenance organizations (HMOs), and prospective budgets.
To address the societal and ethical considerations of allocating resources for marginal life extension.

Main Methods:

Analysis of expert viewpoints on healthcare regulation and market dynamics.
Review of policy implications for healthcare financing and delivery.
Ethical examination of resource allocation for life-prolonging treatments.

Main Results:

Disagreement on the specific mechanisms for effective healthcare cost control and deregulation.
Emphasis on the interplay between regulation, competition, and provider structures (PPOs, HMOs).
Identification of a fundamental societal question regarding the value placed on incremental life extension.

Conclusions:

Achieving healthcare cost control necessitates a nuanced approach to regulation and competition.
Societal values and ethical frameworks are crucial in determining resource allocation for healthcare.
Decisions on funding marginal life extension require careful consideration at an appropriate societal level.

Related Experiment Videos